Profile

New User

New to Graphy Publications? Create an account to get started today.

Registered Users

Have an account? Sign in now.

How to Cite | Author Information | Publication History
International Journal of Clinical Research & Trials Volume 1 (2016), Article ID 1:IJCRT-110, 5 pages
https://doi.org/10.15344/2456-8007/2016/110
Case Study
Market Access for New Medical Technology in South Korea: A Case Study in Health Technology Assessment Policy Development and Implementation

Sang-Soo Lee1* and Eugene Salole2

1Corporate Affairs Director, Medtronic Korea Ltd., Seoul, Korea
2Principal, Value-Based Access Pty Ltd., Sydney, Australia
Mr. Sang-Soo Lee, Corporate Affairs Director, Medtronic Korea Ltd., Seoul, South Korea; E-mail: sang.soo.lee@medtronic.com
30 October 2016; 19 December 2016; 22 December 2016
Lee SS, Salole E (2016) Market Access for New Medical Technology in South Korea: A Case Study in Health Technology Assessment Policy Development and Implementation. Int J Clin Res Trials 1: 110. doi: https://doi.org/10.15344/2456-8007/2016/110
© 2016 Lee et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

References

  1. Lee SS, Salole E (2014) Medical device reimbursement coverage and pricing rules in Korea: current practice and issues with access to innovation. Value Health 17:476-481 [CrossRef] [Google Scholar] [PubMed]
  2. Medical Service Act. Ministry of Government Legislation
  3. nHTA public information brochure (2014) Center for new Health Technology Assessment, National Evidence-based Healthcare Collaborating Agency (NECA)
  4. Yim EY, Lim SH, Oh MJ, Park HK, Gong JR, et al. (2012) Assessment of pharmacoeconomic evaluations submitted for reimbursement in Korea. Value Health 15: S104-S110 [CrossRef] [Google Scholar] [PubMed]
  5. Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [Google Scholar]
  6. NECA’s public presentation to medical device industry at the industry conference (2014)
  7. Ministry of Health and Welfare (MOHW) (2012) Publicized meeting handout and discussion summary
  8. Ministry of Health and Welfare (MOHW) (2013) Publicized meeting handouts and discussion summaries of special task force for nHTA program-August 28, 2013 through January 3, 2014
  9. Ministry of Health and Welfare (MOHW) (2014) Regulations on ‘Committee for new Health Technology Assessment’ operation. MOHW Notice 61
  10. Ministry of Health and Welfare (MOHW) (2014) Revision on ‘Regulations on procedure and method, etc. for nHTA program’. MOHW Notice 2014-125
  11. Ministry of Health and Welfare (MOHW) (2014) Regulation on ‘Conditional nHTA Approval’. MOHW Notice 2014-59
  12. Tunis SR, Pearson SD (2016) Coverage options for promising technologies: Medicare's 'coverage with evidence development'. Health Aff (Millwood) 25:1218-1230 [CrossRef] [Google Scholar] [PubMed]
  13. Goeree R, Chandra K, Tarride JE, O'Reilly D, Xie F, et al. (2010) Conditionally funded field evaluations: PATHs coverage with evidence development program for Ontario. Value Health 13: S8-S11 [CrossRef] [Google Scholar] [PubMed]
  14. Trueman P, Grainger DL, Downs KE (2010) Coverage with Evidence Development: Applications and issues. Int J Technol Assess Health Care 26: 79-85 [CrossRef] [Google Scholar] [PubMed]
  15. Lee SW (2016) Conditional approval system of health technology. Evidence and Values in Healthcare 2016
  16. Ministry of Health and Welfare (MOHW) (2015) Revised regulation on the criteria about national health insurance reimbursement. MOHW Notice 352
  17. Ministry of Health and Welfare (MOHW) (2015) Revised regulation on new Health Technology Assessment. MOHW Notice 353
  18. National Evidence-based Healthcare Collaborating Agency (NECA) (2015). Guidebook about the deferment program of nHTA and criteria on comparative clinical literatures. Announced October 20, 2015
  19. Regulatory Reform Committee
  20. Ministry of Health and Welfare (MOHW) (2016) Joint press release. Single application program for combining regulatory and nHTA submissions [View]
  21. Ministry of Health and Welfare (MOHW) (2015) Press release. ‘Launch of healthcare industry advancement committee under Presidential Office for preparing pan-governmental medical industry development and healthcare system improvement’ [View]
  22. Ministry of Health and Welfare (MOHW) (2009) Press release. ‘Operation of task force for healthcare industry competitiveness enhancement [View]
  23. Ministry of Health and Welfare (MOHW) (2010) Press release. ‘Take-off in medical device industry aiming at global 10th rank by 2015-Plan for medical device industry development’ [View]
  24. Ministry of Health and Welfare (MOHW) (2005) Press release. ‘Discussion about financing to medical institutions – MOHW will actively drive medical service development plan [View]
  25. Ministry of Health and Welfare (MOHW) (2005) Press release. ‘Confirmation on some subjects among healthcare system improvement plans for medical service competitiveness enhancement’ [View]
  26. Ministry of Health and Welfare (MOHW) (2005) Press release. ‘Discussion on medical service competitiveness enhancement at service industryrelevant ministerial meeting’ [View]
  27. Ministry of Health and Welfare (MOHW) (2014) Press release. ‘Mid-/longterm development plan for medical device industry aiming at global 7th rank by 2020 [View]
  28. Ministry of Health and Welfare (MOHW) (2016) OECD Health Data 2015
  29. Ministry of Strategy and Finance (MOSF) (2014) Press release. ‘Measures to stimulate investment: Fostering promising service industries’
Best viewed in Mozilla Firefox, Google Chrome, Safari, Above IE 9.0 version
Privacy Policy | Copyright & Permissions
Copyright © 2013-2024 Graphy Publications, All Rights Reserved.